Effect of Vitamin C Supplementation on Oxidative Stress and Lipid Profiles in Hemodialysis Patients

被引:41
作者
Abdollahzad, Hadi [2 ,3 ]
Eghtesadi, Shahriar [3 ]
Nourmohammadi, Issa [4 ]
Khadem-Ansari, Mohammadhasan [5 ]
Nejad-Gashti, Hossein [6 ]
Esmaillzadeh, Ahmad [1 ]
机构
[1] Isfahan Univ Med Sci, Sch Publ Hlth, Dept Nutr, Esfahan, Iran
[2] Zabol Univ Med Sci, Sch Hlth, Tehran, Iran
[3] Iran Univ Med Sci, Sch Hlth, Dept Nutr, Tehran, Iran
[4] Iran Univ Med Sci, Sch Paramed Sci, Dept Biochem, Tehran, Iran
[5] Urmia Univ Med Sci, Sch Paramed Sci, Dept Biochem, Orumiyeh, Iran
[6] Iran Univ Med Sci, Sch Med, Dept Nephrol, Tehran, Iran
关键词
Vitamin C; malondialdehyde; oxidative stress; hemodialysis; lipids; cardiovascular disease; CARDIOVASCULAR-DISEASE; SERUM MALONDIALDEHYDE; OXIDANT STRESS; RENAL-FAILURE; ANTIOXIDANT; SUSCEPTIBILITY; CHOLESTEROL; PREVENTION; LDL;
D O I
10.1024/0300-9831.79.56.281
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Background and aims: The increase in oxidative stress is the main factor in acceleration of atherosclerosis, leading to death in hemodialysis patients. Vitamin C is one of the most important antioxidants that inhibits lipid peroxidation and improves endothelial function. This study aims to assess the effects of vitamin C supplementation on lipid profiles as well as markers of lipid peroxidation among hemodialysis patients. Materials and methods: In this double-blind, randomized, controlled clinical trial, a total of 42 patients were randomly assigned to vitamin C (n=21) or placebo groups (n=21). Patients in the vitamin C group consumed 250 mg vitamin C and those in the placebo group were given placebo every other day for 12 weeks. Fasting blood samples were collected at baseline and at the end of the study to measure serum concentrations of lipid profiles, as well as malondialdehyde (MDA) and vitamin C. Results: After supplementation with vitamin C, serum vitamin C levels increased significantly in the vitamin C group as compared to baseline (p=0.033). There was also a significant difference in serum vitamin C levels between vitamin C and placebo groups (p=0.001). Serum MDA concentrations were marginally decreased in the vitamin C group after taking supplements (p=0.057). A significant difference was also seen in mean MDA changes between vitamin C and placebo groups (p=0.002). There was a significant difference in serum levels of total cholesterol (p=0.005), low-density lipoprotein (LDL-C) (p=0.012), and LDL-C/high-density lipoprotein (HDL-C) ratio (p=0.018) between the two groups; however, serum triglyceride and HDL-C levels were not significantly different between groups. Conclusion: Every other day supplementation with 250 mg vitamin C for 12 weeks increases serum vitamin C, decreases MDA levels, and improves lipid profiles in hemodialysis patients.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 34 条
[1]
Anderson D, 1997, ENVIRON MOL MUTAGEN, V30, P161, DOI 10.1002/(SICI)1098-2280(1997)30:2<161::AID-EM9>3.0.CO
[2]
2-Q
[3]
Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis [J].
Boaz, M ;
Matas, Z ;
Biro, A ;
Katzir, Z ;
Green, M ;
Fainaru, M ;
Smetana, S .
KIDNEY INTERNATIONAL, 1999, 56 (03) :1078-1083
[4]
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[5]
n-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects [J].
Bonanome, A ;
Biasia, F ;
DeLuca, M ;
Munaretto, G ;
Biffanti, S ;
Pradella, M ;
Pagnan, A .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1996, 63 (02) :261-266
[6]
Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients [J].
Candan, F ;
Gültekin, F ;
Candan, F .
CELL BIOCHEMISTRY AND FUNCTION, 2002, 20 (02) :95-98
[7]
Vitamin C and E supplements improve the impaired antioxidant status and decrease plasma lipid peroxides in hemodialysis patients [J].
Chao, JCJ ;
Yuan, MD ;
Chen, PY ;
Chien, SW .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2002, 13 (11) :653-663
[8]
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients [J].
Clermont, G ;
Lecour, S ;
Lahet, JJ ;
Siohan, P ;
Vergely, C ;
Chevet, D ;
Rifle, G ;
Rochette, L .
CARDIOVASCULAR RESEARCH, 2000, 47 (03) :618-623
[9]
CRISTOL JP, 1994, NEPHROL DIAL TRANSPL, V9, P389
[10]
Vitamin C in chronic kidney disease and hemodialysis patients [J].
Deicher, R ;
Hörl, WH .
KIDNEY & BLOOD PRESSURE RESEARCH, 2003, 26 (02) :100-106